A citation-based method for searching scientific literature

W Burke, J O Culver, D Bowen, D Lowry, S Durfy, A McTiernan, M R Andersen. Am J Med Genet 2000
Times Cited: 77







List of co-cited articles
618 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
349
31

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
27

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
276
27

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
25

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
434
24

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997
697
24

The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
M Watson, S Lloyd, J Davidson, L Meyer, R Eeles, S Ebbs, V Murday. Br J Cancer 1999
184
22


Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
398
22

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
22

Genetic analysis of breast cancer in the cancer and steroid hormone study.
E B Claus, N Risch, W D Thompson. Am J Hum Genet 1991
754
20

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
19


Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.
P Hopwood, F Keeling, A Long, C Pool, G Evans, A Howell. Psychooncology 1998
90
18

Family history of breast cancer: what do women understand and recall about their genetic risk?
M Watson, V Duvivier, M Wade Walsh, S Ashley, J Davidson, M Papaikonomou, V Murday, N Sacks, R Eeles. J Med Genet 1998
111
16


Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
145
16

Breast cancer risk counseling improves women's functioning.
Deborah J Bowen, Wylie Burke, Anne McTiernan, Yutaka Yasui, M Robyn Andersen. Patient Educ Couns 2004
54
24

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
15

The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress.
A Cull, E D Anderson, S Campbell, J Mackay, E Smyth, M Steel. Br J Cancer 1999
121
15

Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
116
15

The impact of genetic counselling on risk perception in women with a family history of breast cancer.
D G Evans, V Blair, R Greenhalgh, P Hopwood, A Howell. Br J Cancer 1994
138
15


Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
T R Rebbeck, A M Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, C Isaacs, O Olopade, J E Garber, A K Godwin,[...]. J Natl Cancer Inst 1999
464
14

Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.
Deborah J Bowen, Wylie Burke, Yutaka Yasui, Anne McTiernan, Dale McLeran. Genet Med 2002
30
36

Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
432
12



Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families.
J K Tobacman, M H Greene, M A Tucker, J Costa, R Kase, J F Fraumeni. Lancet 1982
297
12

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
12

Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.
E S Tambor, B A Bernhardt, G A Chase, R R Faden, G Geller, K J Hofman, N A Holtzman. Am J Hum Genet 1994
135
12

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
225
12

Perception of risk in women with a family history of breast cancer.
D G Evans, L D Burnell, P Hopwood, A Howell. Br J Cancer 1993
142
12




Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
B Meiser, P Butow, A Barratt, M Friedlander, M Gattas, J Kirk, G Suthers, I Walpole, K Tucker. Gynecol Oncol 1999
62
14

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
11

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
11


Prophylactic oophorectomy.
W J Meijer, A C van Lindert. Eur J Obstet Gynecol Reprod Biol 1992
44
20

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.
F S Leach, N C Nicolaides, N Papadopoulos, B Liu, J Jen, R Parsons, P Peltomäki, P Sistonen, L A Aaltonen, M Nyström-Lahti. Cell 1993
11

Contribution of BRCA1 mutations to ovarian cancer.
J F Stratton, S A Gayther, P Russell, J Dearden, M Gore, P Blake, D Easton, B A Ponder. N Engl J Med 1997
197
11

Participation in breast cancer risk counseling among women with a family history.
D Bowen, A McTiernan, W Burke, D Powers, J Pruski, S Durfy, J Gralow, K Malone. Cancer Epidemiol Biomarkers Prev 1999
36
25


Psychological counseling strategies for women at risk of breast cancer.
K M Kash, J C Holland, M P Osborne, D G Miller. J Natl Cancer Inst Monogr 1995
57
14

Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
127
10

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
F J Couch, M L DeShano, M A Blackwood, K Calzone, J Stopfer, L Campeau, A Ganguly, T Rebbeck, B L Weber. N Engl J Med 1997
523
10

The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
139
10

Satellited 4q identified in amniotic fluid cells.
I Miller, G Songster, S Fontana, C L Hsieh. Am J Med Genet 1995
18
44


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.